nodes	percent_of_prediction	percent_of_DWPC	metapath
Altretamine—ovarian cancer—testicular cancer	0.359	1	CtDrD
Altretamine—Alkylating Activity—Ifosfamide—testicular cancer	0.322	0.529	CiPCiCtD
Altretamine—Alkylating Activity—Chlorambucil—testicular cancer	0.287	0.471	CiPCiCtD
Altretamine—Myelosuppression—Vinblastine—testicular cancer	0.00114	0.0352	CcSEcCtD
Altretamine—Neurological symptom—Cisplatin—testicular cancer	0.0011	0.0341	CcSEcCtD
Altretamine—Neurotoxicity—Ifosfamide—testicular cancer	0.000993	0.0308	CcSEcCtD
Altretamine—Myelosuppression—Bleomycin—testicular cancer	0.00096	0.0298	CcSEcCtD
Altretamine—Myelosuppression—Dactinomycin—testicular cancer	0.000896	0.0278	CcSEcCtD
Altretamine—Neurotoxicity—Cisplatin—testicular cancer	0.000856	0.0265	CcSEcCtD
Altretamine—Myelosuppression—Ifosfamide—testicular cancer	0.000821	0.0254	CcSEcCtD
Altretamine—Neurotoxicity—Etoposide—testicular cancer	0.000784	0.0243	CcSEcCtD
Altretamine—Myelosuppression—Cisplatin—testicular cancer	0.000708	0.0219	CcSEcCtD
Altretamine—Neoplasm malignant—Chlorambucil—testicular cancer	0.000681	0.0211	CcSEcCtD
Altretamine—Myelosuppression—Etoposide—testicular cancer	0.000648	0.0201	CcSEcCtD
Altretamine—Peripheral sensory neuropathy—Epirubicin—testicular cancer	0.000596	0.0185	CcSEcCtD
Altretamine—Peripheral sensory neuropathy—Doxorubicin—testicular cancer	0.000552	0.0171	CcSEcCtD
Altretamine—Neoplasm—Chlorambucil—testicular cancer	0.000526	0.0163	CcSEcCtD
Altretamine—Neoplasm—Vinblastine—testicular cancer	0.000482	0.0149	CcSEcCtD
Altretamine—Neurotoxicity—Methotrexate—testicular cancer	0.00047	0.0146	CcSEcCtD
Altretamine—Neoplasm malignant—Ifosfamide—testicular cancer	0.000451	0.014	CcSEcCtD
Altretamine—Neurotoxicity—Epirubicin—testicular cancer	0.000439	0.0136	CcSEcCtD
Altretamine—Neurotoxicity—Doxorubicin—testicular cancer	0.000407	0.0126	CcSEcCtD
Altretamine—Ataxia—Chlorambucil—testicular cancer	0.000397	0.0123	CcSEcCtD
Altretamine—Myelosuppression—Epirubicin—testicular cancer	0.000363	0.0113	CcSEcCtD
Altretamine—Neoplasm—Ifosfamide—testicular cancer	0.000348	0.0108	CcSEcCtD
Altretamine—Pancytopenia—Chlorambucil—testicular cancer	0.000347	0.0107	CcSEcCtD
Altretamine—Myelosuppression—Doxorubicin—testicular cancer	0.000336	0.0104	CcSEcCtD
Altretamine—Neuropathy peripheral—Chlorambucil—testicular cancer	0.000319	0.00989	CcSEcCtD
Altretamine—Pancytopenia—Vinblastine—testicular cancer	0.000318	0.00985	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Etoposide—testicular cancer	0.000304	0.00942	CcSEcCtD
Altretamine—Neuropathy peripheral—Vinblastine—testicular cancer	0.000292	0.00906	CcSEcCtD
Altretamine—Pancytopenia—Bleomycin—testicular cancer	0.000268	0.00832	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Etoposide—testicular cancer	0.000254	0.00786	CcSEcCtD
Altretamine—Pancytopenia—Dactinomycin—testicular cancer	0.00025	0.00776	CcSEcCtD
Altretamine—Anaemia—Chlorambucil—testicular cancer	0.000235	0.00729	CcSEcCtD
Altretamine—Pancytopenia—Ifosfamide—testicular cancer	0.000229	0.00711	CcSEcCtD
Altretamine—Leukopenia—Chlorambucil—testicular cancer	0.000228	0.00706	CcSEcCtD
Altretamine—Convulsion—Chlorambucil—testicular cancer	0.00022	0.00683	CcSEcCtD
Altretamine—Anaemia—Vinblastine—testicular cancer	0.000215	0.00668	CcSEcCtD
Altretamine—Neuropathy peripheral—Ifosfamide—testicular cancer	0.000211	0.00654	CcSEcCtD
Altretamine—Vertigo—Vinblastine—testicular cancer	0.000209	0.00649	CcSEcCtD
Altretamine—Leukopenia—Vinblastine—testicular cancer	0.000209	0.00647	CcSEcCtD
Altretamine—Thrombocytopenia—Chlorambucil—testicular cancer	0.000203	0.0063	CcSEcCtD
Altretamine—Convulsion—Vinblastine—testicular cancer	0.000202	0.00626	CcSEcCtD
Altretamine—Neoplasm malignant—Epirubicin—testicular cancer	0.0002	0.00618	CcSEcCtD
Altretamine—Anorexia—Chlorambucil—testicular cancer	0.000198	0.00613	CcSEcCtD
Altretamine—Pancytopenia—Cisplatin—testicular cancer	0.000198	0.00613	CcSEcCtD
Altretamine—Thrombocytopenia—Vinblastine—testicular cancer	0.000186	0.00577	CcSEcCtD
Altretamine—Neoplasm malignant—Doxorubicin—testicular cancer	0.000185	0.00572	CcSEcCtD
Altretamine—Anaemia—Bleomycin—testicular cancer	0.000182	0.00564	CcSEcCtD
Altretamine—Neuropathy peripheral—Cisplatin—testicular cancer	0.000182	0.00564	CcSEcCtD
Altretamine—Anorexia—Vinblastine—testicular cancer	0.000181	0.00562	CcSEcCtD
Altretamine—Pancytopenia—Etoposide—testicular cancer	0.000181	0.00561	CcSEcCtD
Altretamine—Decreased appetite—Chlorambucil—testicular cancer	0.00018	0.00559	CcSEcCtD
Altretamine—Fatigue—Chlorambucil—testicular cancer	0.000179	0.00555	CcSEcCtD
Altretamine—Leukopenia—Bleomycin—testicular cancer	0.000176	0.00546	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Epirubicin—testicular cancer	0.00017	0.00528	CcSEcCtD
Altretamine—Anaemia—Dactinomycin—testicular cancer	0.00017	0.00526	CcSEcCtD
Altretamine—Neuropathy peripheral—Etoposide—testicular cancer	0.000167	0.00517	CcSEcCtD
Altretamine—Decreased appetite—Vinblastine—testicular cancer	0.000165	0.00513	CcSEcCtD
Altretamine—Neoplasm—Methotrexate—testicular cancer	0.000165	0.0051	CcSEcCtD
Altretamine—Leukopenia—Dactinomycin—testicular cancer	0.000164	0.00509	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Doxorubicin—testicular cancer	0.000158	0.00489	CcSEcCtD
Altretamine—Thrombocytopenia—Bleomycin—testicular cancer	0.000157	0.00488	CcSEcCtD
Altretamine—Anaemia—Ifosfamide—testicular cancer	0.000156	0.00482	CcSEcCtD
Altretamine—Neoplasm—Epirubicin—testicular cancer	0.000154	0.00477	CcSEcCtD
Altretamine—Anorexia—Bleomycin—testicular cancer	0.000153	0.00475	CcSEcCtD
Altretamine—Vertigo—Ifosfamide—testicular cancer	0.000151	0.00468	CcSEcCtD
Altretamine—Leukopenia—Ifosfamide—testicular cancer	0.000151	0.00467	CcSEcCtD
Altretamine—Asthenia—Chlorambucil—testicular cancer	0.000149	0.00462	CcSEcCtD
Altretamine—Thrombocytopenia—Dactinomycin—testicular cancer	0.000147	0.00455	CcSEcCtD
Altretamine—Convulsion—Ifosfamide—testicular cancer	0.000146	0.00452	CcSEcCtD
Altretamine—Anorexia—Dactinomycin—testicular cancer	0.000143	0.00443	CcSEcCtD
Altretamine—Neoplasm—Doxorubicin—testicular cancer	0.000143	0.00442	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Epirubicin—testicular cancer	0.000142	0.00441	CcSEcCtD
Altretamine—Decreased appetite—Bleomycin—testicular cancer	0.00014	0.00433	CcSEcCtD
Altretamine—Asthenia—Vinblastine—testicular cancer	0.000136	0.00423	CcSEcCtD
Altretamine—Thrombocytopenia—Ifosfamide—testicular cancer	0.000134	0.00417	CcSEcCtD
Altretamine—Anaemia—Cisplatin—testicular cancer	0.000134	0.00415	CcSEcCtD
Altretamine—Vomiting—Chlorambucil—testicular cancer	0.000132	0.00409	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Doxorubicin—testicular cancer	0.000132	0.00408	CcSEcCtD
Altretamine—Anorexia—Ifosfamide—testicular cancer	0.000131	0.00406	CcSEcCtD
Altretamine—Decreased appetite—Dactinomycin—testicular cancer	0.00013	0.00404	CcSEcCtD
Altretamine—Leukopenia—Cisplatin—testicular cancer	0.00013	0.00402	CcSEcCtD
Altretamine—Fatigue—Dactinomycin—testicular cancer	0.000129	0.004	CcSEcCtD
Altretamine—Dizziness—Vinblastine—testicular cancer	0.000126	0.0039	CcSEcCtD
Altretamine—Convulsion—Cisplatin—testicular cancer	0.000126	0.00389	CcSEcCtD
Altretamine—Ataxia—Methotrexate—testicular cancer	0.000124	0.00385	CcSEcCtD
Altretamine—Nausea—Chlorambucil—testicular cancer	0.000123	0.00382	CcSEcCtD
Altretamine—Anaemia—Etoposide—testicular cancer	0.000123	0.00381	CcSEcCtD
Altretamine—Vomiting—Vinblastine—testicular cancer	0.000121	0.00375	CcSEcCtD
Altretamine—Vertigo—Etoposide—testicular cancer	0.000119	0.0037	CcSEcCtD
Altretamine—Decreased appetite—Ifosfamide—testicular cancer	0.000119	0.0037	CcSEcCtD
Altretamine—Leukopenia—Etoposide—testicular cancer	0.000119	0.00369	CcSEcCtD
Altretamine—Fatigue—Ifosfamide—testicular cancer	0.000118	0.00367	CcSEcCtD
Altretamine—Ataxia—Epirubicin—testicular cancer	0.000116	0.0036	CcSEcCtD
Altretamine—Thrombocytopenia—Cisplatin—testicular cancer	0.000116	0.00359	CcSEcCtD
Altretamine—Asthenia—Bleomycin—testicular cancer	0.000115	0.00357	CcSEcCtD
Altretamine—Convulsion—Etoposide—testicular cancer	0.000115	0.00357	CcSEcCtD
Altretamine—Nausea—Vinblastine—testicular cancer	0.000113	0.0035	CcSEcCtD
Altretamine—Anorexia—Cisplatin—testicular cancer	0.000113	0.0035	CcSEcCtD
Altretamine—Pancytopenia—Methotrexate—testicular cancer	0.000108	0.00336	CcSEcCtD
Altretamine—Ataxia—Doxorubicin—testicular cancer	0.000108	0.00334	CcSEcCtD
Altretamine—Asthenia—Dactinomycin—testicular cancer	0.000108	0.00333	CcSEcCtD
Altretamine—Thrombocytopenia—Etoposide—testicular cancer	0.000106	0.00329	CcSEcCtD
Altretamine—Anorexia—Etoposide—testicular cancer	0.000103	0.0032	CcSEcCtD
Altretamine—Decreased appetite—Cisplatin—testicular cancer	0.000103	0.00319	CcSEcCtD
Altretamine—Vomiting—Bleomycin—testicular cancer	0.000102	0.00317	CcSEcCtD
Altretamine—Pancytopenia—Epirubicin—testicular cancer	0.000102	0.00315	CcSEcCtD
Altretamine—Asthenia—Ifosfamide—testicular cancer	9.85e-05	0.00305	CcSEcCtD
Altretamine—Nausea—Bleomycin—testicular cancer	9.54e-05	0.00296	CcSEcCtD
Altretamine—Vomiting—Dactinomycin—testicular cancer	9.53e-05	0.00295	CcSEcCtD
Altretamine—Decreased appetite—Etoposide—testicular cancer	9.43e-05	0.00292	CcSEcCtD
Altretamine—Pancytopenia—Doxorubicin—testicular cancer	9.39e-05	0.00291	CcSEcCtD
Altretamine—Fatigue—Etoposide—testicular cancer	9.35e-05	0.0029	CcSEcCtD
Altretamine—Neuropathy peripheral—Epirubicin—testicular cancer	9.34e-05	0.0029	CcSEcCtD
Altretamine—Dizziness—Ifosfamide—testicular cancer	9.08e-05	0.00281	CcSEcCtD
Altretamine—Nausea—Dactinomycin—testicular cancer	8.9e-05	0.00276	CcSEcCtD
Altretamine—Vomiting—Ifosfamide—testicular cancer	8.73e-05	0.00271	CcSEcCtD
Altretamine—Neuropathy peripheral—Doxorubicin—testicular cancer	8.65e-05	0.00268	CcSEcCtD
Altretamine—Asthenia—Cisplatin—testicular cancer	8.49e-05	0.00263	CcSEcCtD
Altretamine—Nausea—Ifosfamide—testicular cancer	8.16e-05	0.00253	CcSEcCtD
Altretamine—Asthenia—Etoposide—testicular cancer	7.78e-05	0.00241	CcSEcCtD
Altretamine—Vomiting—Cisplatin—testicular cancer	7.53e-05	0.00233	CcSEcCtD
Altretamine—Anaemia—Methotrexate—testicular cancer	7.36e-05	0.00228	CcSEcCtD
Altretamine—Dizziness—Etoposide—testicular cancer	7.17e-05	0.00222	CcSEcCtD
Altretamine—Vertigo—Methotrexate—testicular cancer	7.15e-05	0.00222	CcSEcCtD
Altretamine—Leukopenia—Methotrexate—testicular cancer	7.12e-05	0.00221	CcSEcCtD
Altretamine—Nausea—Cisplatin—testicular cancer	7.03e-05	0.00218	CcSEcCtD
Altretamine—Convulsion—Methotrexate—testicular cancer	6.9e-05	0.00214	CcSEcCtD
Altretamine—Vomiting—Etoposide—testicular cancer	6.9e-05	0.00214	CcSEcCtD
Altretamine—Anaemia—Epirubicin—testicular cancer	6.88e-05	0.00213	CcSEcCtD
Altretamine—Vertigo—Epirubicin—testicular cancer	6.69e-05	0.00207	CcSEcCtD
Altretamine—Leukopenia—Epirubicin—testicular cancer	6.67e-05	0.00207	CcSEcCtD
Altretamine—Convulsion—Epirubicin—testicular cancer	6.45e-05	0.002	CcSEcCtD
Altretamine—Nausea—Etoposide—testicular cancer	6.44e-05	0.002	CcSEcCtD
Altretamine—Anaemia—Doxorubicin—testicular cancer	6.37e-05	0.00197	CcSEcCtD
Altretamine—Thrombocytopenia—Methotrexate—testicular cancer	6.36e-05	0.00197	CcSEcCtD
Altretamine—Vertigo—Doxorubicin—testicular cancer	6.19e-05	0.00192	CcSEcCtD
Altretamine—Anorexia—Methotrexate—testicular cancer	6.19e-05	0.00192	CcSEcCtD
Altretamine—Leukopenia—Doxorubicin—testicular cancer	6.17e-05	0.00191	CcSEcCtD
Altretamine—Convulsion—Doxorubicin—testicular cancer	5.97e-05	0.00185	CcSEcCtD
Altretamine—Thrombocytopenia—Epirubicin—testicular cancer	5.95e-05	0.00184	CcSEcCtD
Altretamine—Anorexia—Epirubicin—testicular cancer	5.79e-05	0.0018	CcSEcCtD
Altretamine—Decreased appetite—Methotrexate—testicular cancer	5.65e-05	0.00175	CcSEcCtD
Altretamine—Fatigue—Methotrexate—testicular cancer	5.6e-05	0.00174	CcSEcCtD
Altretamine—Thrombocytopenia—Doxorubicin—testicular cancer	5.51e-05	0.00171	CcSEcCtD
Altretamine—Anorexia—Doxorubicin—testicular cancer	5.36e-05	0.00166	CcSEcCtD
Altretamine—Decreased appetite—Epirubicin—testicular cancer	5.28e-05	0.00164	CcSEcCtD
Altretamine—Fatigue—Epirubicin—testicular cancer	5.24e-05	0.00162	CcSEcCtD
Altretamine—Decreased appetite—Doxorubicin—testicular cancer	4.89e-05	0.00152	CcSEcCtD
Altretamine—Fatigue—Doxorubicin—testicular cancer	4.85e-05	0.0015	CcSEcCtD
Altretamine—Asthenia—Methotrexate—testicular cancer	4.66e-05	0.00144	CcSEcCtD
Altretamine—Asthenia—Epirubicin—testicular cancer	4.36e-05	0.00135	CcSEcCtD
Altretamine—Dizziness—Methotrexate—testicular cancer	4.3e-05	0.00133	CcSEcCtD
Altretamine—Vomiting—Methotrexate—testicular cancer	4.13e-05	0.00128	CcSEcCtD
Altretamine—Asthenia—Doxorubicin—testicular cancer	4.04e-05	0.00125	CcSEcCtD
Altretamine—Dizziness—Epirubicin—testicular cancer	4.02e-05	0.00125	CcSEcCtD
Altretamine—Vomiting—Epirubicin—testicular cancer	3.87e-05	0.0012	CcSEcCtD
Altretamine—Nausea—Methotrexate—testicular cancer	3.86e-05	0.0012	CcSEcCtD
Altretamine—Dizziness—Doxorubicin—testicular cancer	3.72e-05	0.00115	CcSEcCtD
Altretamine—Nausea—Epirubicin—testicular cancer	3.61e-05	0.00112	CcSEcCtD
Altretamine—Vomiting—Doxorubicin—testicular cancer	3.58e-05	0.00111	CcSEcCtD
Altretamine—Nausea—Doxorubicin—testicular cancer	3.34e-05	0.00104	CcSEcCtD
